Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 100. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_323	Canine parvovirus	CPV2.NS1	DNA	Paroviridae	CPV genome expressing non-structural protein (NS1)	Yes	No	No	NCCS (National Centre for Cell Science, Pune, India)	Human cervical cancer cell line	HeLa	density of E+4 to E+5 cells/well in 120 microlitres of culture medium	NA	LDH assay	NA	9% cancer cell death at 24 hours	No	No	NA	No response	NA	Apoptosis is induced via mitochondrial depolarization, release of cytochrome-c and activation of caspase 9	NA	NA	26555166
OV_324	Canine parvovirus	CPV2.NS1	DNA	Paroviridae	CPV genome expressing non-structural protein (NS1)	Yes	No	No	NCCS (National Centre for Cell Science, Pune, India)	Human cervical cancer cell line	HeLa	density of E+4 to E+5 cells/well in 120 microlitres of culture medium	NA	LDH assay	NA	18% cancer cell death at 48 hours	No	No	NA	No response	NA	Apoptosis is induced via mitochondrial depolarization, release of cytochrome-c and activation of caspase 9	NA	NA	26555166
OV_402	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	110% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_404	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	118% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_406	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	98% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_408	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	78% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_410	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	30% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_412	Adenovirus	CRAd-IL24 (Ad5/3Î”24cmvIL24)	DNA	Adenoviridae	Viral mutanat with IL-24 gene incorporated in place of the deleted E3B region (Î”E3B) under transcriptional control of the human CMV promoter (CMVp).	Yes	No	IL-24 gene incorporated in place of the deleted E3B region	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	18% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_426	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	0.4 MOI	110% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_428	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	1 MOI	130% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_430	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	4 MOI	116% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_432	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	11 MOI	100% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_434	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	33 MOI	50% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_436	Adenovirus	CRAd-ING4 (Ad5/3Î”24cmvING4)	DNA	Adenoviridae	Viral mutanat with CMVp-driven Inhibitor of Growth 4 (ING4) gene	Yes	No	No	ATCC	Human cervical squamous cell carcinoma cell line	OV-4	3.0E+5 to 5.0E+5 cells per well	Toxic to normal ovarian surface epithelial IOSE-120 and IOSE-523 cells	MTS-based Cell Proliferation Assay (Promega)	100 MOI	16% cancer cell viability (percentages are calculated with respect to mock-infected cell monolayers)	No	No	NA	No response	NA	NA	NA	NA	27349517
OV_607	Adenovirus	CRAd-CCL21-IL15	DNA	Adenoviridae	Insertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cells	Yes	No	IL-15	ATCC	Human cervical cancer cell	HeLa	1.0E+5 cells per well	NA	MTT assay	0.1 MOI	85% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	27380620
OV_610	Adenovirus	CRAd-CCL21-IL15	DNA	Adenoviridae	Insertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cells	Yes	No	IL-15	ATCC	Human cervical cancer cell	HeLa	1.0E+5 cells per well	NA	MTT assay	1 MOI	37% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	27380620
OV_613	Adenovirus	CRAd-CCL21-IL15	DNA	Adenoviridae	Insertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cells	Yes	No	IL-15	ATCC	Human cervical cancer cell	HeLa	1.0E+5 cells per well	NA	MTT assay	10 MOI	8% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	27380620
OV_616	Adenovirus	CRAd-CCL21-IL15	DNA	Adenoviridae	Insertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cells	Yes	No	IL-15	ATCC	Human cervical cancer cell	HeLa	1.0E+5 cells per well	NA	MTT assay	50 MOI	5% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	27380620
OV_1094	Adenovirus	ZD55-IL-24	DNA	Adenoviridae	Adenovirus expressing ZD55 gene and IL-24 gene	Yes	No	Expressing IL-24 gene	Shanghai cell collection	Human cervical carcinoma cell line	HT-29	2.0E+6 cells per well	NA	MTT assay	5 MOI	60% cell killing after 80 hours	No	No	NA	No response	NA	Apoptosis induction and cspase 3 activation	NA	NA	15661558
OV_1095	Adenovirus	Ad-IL-24	DNA	Adenoviridae	Adenovirus expressing IL-24 gene	Yes	No	Expressing IL-24 gene	Shanghai cell collection	Human cervical carcinoma cell line	HT-29	2.0E+6 cells per well	NA	MTT assay	5 MOI	20% cell killing after 80 hours	No	No	NA	No response	NA	Apoptosis induction and cspase 3 activation	NA	NA	15661558
OV_1096	Adenovirus	ZD55-EGFP	DNA	Adenoviridae	Adenovirus expressing EGFP gene	Yes	No	No	Shanghai cell collection	Human cervical carcinoma cell line	HT-29	2.0E+6 cells per well	NA	MTT assay	5 MOI	40% cell killing after 80 hours	No	No	NA	No response	NA	Apoptosis induction and cspase 3 activation	NA	NA	15661558
OV_1097	Adenovirus	ZD55-IL-24	DNA	Adenoviridae	Adenovirus expressing ZD55 gene and IL-24 gene	Yes	No	Expressing IL-24 gene	Shanghai cell collection	Human cervical carcinoma cell line	SW620	2.0E+6 cells per well	NA	MTT assay	5 MOI	No cell killing after 80 hours	No	No	NA	No response	NA	Apoptosis induction and cspase 3 activation	NA	NA	15661558
OV_1098	Adenovirus	Ad-IL-24	DNA	Adenoviridae	Adenovirus expressing IL-24 gene	Yes	No	Expressing IL-24 gene	Shanghai cell collection	Human cervical carcinoma cell line	SW620	2.0E+6 cells per well	NA	MTT assay	5 MOI	No cell killing after 80 hours	No	No	NA	No response	NA	Apoptosis induction and cspase 3 activation	NA	NA	15661558
OV_1099	Adenovirus	ZD55-EGFP	DNA	Adenoviridae	Adenovirus expressing EGFP gene	Yes	No	No	Shanghai cell collection	Human cervical carcinoma cell line	SW620	2.0E+6 cells per well	NA	MTT assay	5 MOI	No cell killing after 80 hours	No	No	NA	No response	NA	Apoptosis induction and cspase 3 activation	NA	NA	15661558
OV_3045	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10â»â´ MOI	30% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3046	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10â»Â³ MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3047	Vaccinia virus	DeltaJ2R/FCU1 VACV	DNA	Poxviridae	Deletion of J2R gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10â»Â² MOI	100% cell death	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3075	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10â»â´ MOI	18% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3076	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10â»Â³ MOI	1% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3077	Vaccinia virus	DeltaJ2R-I4L/FCU1 VACV (TG6002)	DNA	Poxviridae	Deletion of J2R and I4L gene and insertion of gene FCU1	Yes	No	No	ATCC	Human cervical cancer cell line	HeLa	3.0E+5 cells per well	NA	Trypan blue assay	10â»Â² MOI	1% cell viability	No	No	NA	No response	NA	NA	NA	NA	31011628
OV_3661	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	HeLa	5000 cells per well	NA	MTT assay	1 MOI	75% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3662	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	HeLa	5000 cells per well	NA	MTT assay	1 MOI	68% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3663	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	SIHA	5000 cells per well	NA	MTT assay	1 MOI	70% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3664	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	SIHA	5000 cells per well	NA	MTT assay	1 MOI	15% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3677	Mumps virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	HeLa	5000 cells per well	NA	MTT assay	1 MOI	100% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3678	Mumps virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	HeLa	5000 cells per well	NA	MTT assay	1 MOI	70% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3679	Mumps virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	SIHA	5000 cells per well	NA	MTT assay	1 MOI	80% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3680	Mumps virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	SIHA	5000 cells per well	NA	MTT assay	1 MOI	75% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3693	Measles and mumps virus	wild type	RNA	Paramyxoviridae	None	No	Measles virus in combination with mumps virus	No	ATCC	Human cervix cancer cell line	HeLa	5000 cells per well	NA	MTT assay	1 MOI	75% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3694	Measles and mumps virus	wild type	RNA	Paramyxoviridae	None	No	Measles virus in combination with mumps virus	No	ATCC	Human cervix cancer cell line	HeLa	5000 cells per well	NA	MTT assay	1 MOI	70% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3695	Measles and mumps virus	wild type	RNA	Paramyxoviridae	None	No	Measles virus in combination with mumps virus	No	ATCC	Human cervix cancer cell line	SIHA	5000 cells per well	NA	MTT assay	1 MOI	50% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3696	Measles and mumps virus	wild type	RNA	Paramyxoviridae	None	No	Measles virus in combination with mumps virus	No	ATCC	Human cervix cancer cell line	SIHA	5000 cells per well	NA	MTT assay	1 MOI	15% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3803	Newcastle disease virus	NDVstrain 777	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	18% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3804	Newcastle disease virus	NDVstrain 770	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	22% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3805	Newcastle disease virus	NDVstrain 264	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	23% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3806	Newcastle disease virus	NDVstrain 373	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	23% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3807	Newcastle disease virus	NDVstrain 321	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	25% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3808	Newcastle disease virus	NDVstrain 860	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	26% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3809	Newcastle disease virus	NDVstrain 14	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	42% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3810	Newcastle disease virus	NDVstrain 769	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	45% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3811	Newcastle disease virus	NDVstrain 776	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	45% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3812	Newcastle disease virus	NDVstrain 852	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	60% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3813	Newcastle disease virus	NDVstrain 320	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	60% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3814	Newcastle disease virus	NDVstrain AD	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	62% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3815	Newcastle disease virus	NDVstrain 429	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	65% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3816	Newcastle disease virus	NDVstrain 27	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	65% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3817	Newcastle disease virus	NDVstrain 718	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	65% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3818	Newcastle disease virus	NDVstrain 49	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	68% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3819	Newcastle disease virus	NDVstrain 52	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	68% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3820	Newcastle disease virus	NDVstrain 329	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	75% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3821	Newcastle disease virus	NDVstrain 12	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	75% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3822	Newcastle disease virus	NDVstrain 53	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	79% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3823	Newcastle disease virus	NDVstrain 746	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	79% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3824	Newcastle disease virus	NDVstrain 389	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	82% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3825	Newcastle disease virus	NDVstrain 339	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	85% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3826	Newcastle disease virus	NDVstrain 922	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	90% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3827	Newcastle disease virus	NDVstrain 945	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	95% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3828	Newcastle disease virus	NDVstrain 753	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	100% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3829	Newcastle disease virus	NDVstrain 48	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	100% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3830	Newcastle disease virus	NDVstrain 465	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	100% cell viability after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3908	Newcastle disease virus	NDVstrain 264	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	2 HAU	42% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3909	Newcastle disease virus	NDVstrain 264	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	8 HAU	23% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3910	Newcastle disease virus	NDVstrain 264	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	22% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3911	Newcastle disease virus	NDVstrain 320	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	2 HAU	67% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3912	Newcastle disease virus	NDVstrain 320	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	8 HAU	64% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3913	Newcastle disease virus	NDVstrain 320	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	59% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3914	Newcastle disease virus	NDVstrain 321	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	2 HAU	29% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3915	Newcastle disease virus	NDVstrain 321	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	8 HAU	24% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3916	Newcastle disease virus	NDVstrain 321	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	24% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3917	Newcastle disease virus	NDVstrain 373	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	2 HAU	25% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3918	Newcastle disease virus	NDVstrain 373	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	8 HAU	21% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3919	Newcastle disease virus	NDVstrain 373	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	22% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3920	Newcastle disease virus	NDVstrain 770	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	2 HAU	32% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3921	Newcastle disease virus	NDVstrain 770	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	8 HAU	24% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3922	Newcastle disease virus	NDVstrain 770	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	21% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3923	Newcastle disease virus	NDVstrain 852	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	2 HAU	56% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3924	Newcastle disease virus	NDVstrain 852	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	8 HAU	51% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3925	Newcastle disease virus	NDVstrain 852	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	58% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3926	Newcastle disease virus	NDVstrain 776	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	2 HAU	51% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3927	Newcastle disease virus	NDVstrain 776	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	8 HAU	52% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3928	Newcastle disease virus	NDVstrain 776	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	47% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3929	Newcastle disease virus	NDVstrain 769	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	2 HAU	51% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3930	Newcastle disease virus	NDVstrain 769	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	8 HAU	47% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3931	Newcastle disease virus	NDVstrain 769	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	46% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3932	Newcastle disease virus	NDVstrain 860	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	2 HAU	28% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3933	Newcastle disease virus	NDVstrain 860	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	8 HAU	20% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3934	Newcastle disease virus	NDVstrain 860	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	25% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3935	Newcastle disease virus	NDVstrain 777	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	2 HAU	19% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3936	Newcastle disease virus	NDVstrain 777	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	8 HAU	17% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357
OV_3937	Newcastle disease virus	NDVstrain 777	RNA	Paramyxoviridae	None	Yes	No	No	Institute of clinical and experimental lymphology, Russia	Human epitheloid cervix carcinoma	HeLa	10000 cells per well	NA	MTT assay	16 HAU	17% cell survival after 4th day	No	No	NA	No response	NA	Virus induces apoptosis, necrosis and autophagy in cancer cells	Induction of MARK signalling pathway	NA	29621357

previous12 next